BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Long-Term Debt
BRAIN Biotech AG
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Long-Term Debt
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Long-Term Debt
€1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evonik Industries AG
XETRA:EVK
|
Long-Term Debt
€3.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
19%
|
|
Covestro AG
XETRA:1COV
|
Long-Term Debt
€2.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Long-Term Debt
€52m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Long-Term Debt
€2.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
19%
|
See Also
What is BRAIN Biotech AG's Long-Term Debt?
Long-Term Debt
0
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Long-Term Debt amounts to 0 EUR.